Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Global Surveillance for Antituberculosis-Drug Resistance, 1994–1997
1998639 citationsAriel Pablos-Méndez, Mario Raviǵlione et al.New England Journal of Medicineprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of P Chaulet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Chaulet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Chaulet more than expected).
This network shows the impact of papers produced by P Chaulet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Chaulet. The network helps show where P Chaulet may publish in the future.
Co-authorship network of co-authors of P Chaulet
This figure shows the co-authorship network connecting the top 25 collaborators of P Chaulet.
A scholar is included among the top collaborators of P Chaulet based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with P Chaulet. P Chaulet is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Laid, Youcef, et al.. (2009). Practical approach to lung health in Algeria.. The International Journal of Tuberculosis and Lung Disease. 13(8). 1029–1037.2 indexed citations
3.
Laid, Youcef, et al.. (2009). L'approche pratique de la santé respiratoire en Algérie. The International Journal of Tuberculosis and Lung Disease. 13(8). 1029–1037.3 indexed citations
4.
Chaulet, P, Ian M. Campbell, & Charles Boelen. (1998). Tuberculosis control and medical schools : report of a WHO workshop, Rome, Italy, 29-31 October, 1997. World Health Organization eBooks.2 indexed citations
5.
Pablos-Méndez, Ariel, Mario Raviǵlione, A László, et al.. (1998). Global Surveillance for Antituberculosis-Drug Resistance, 1994–1997. New England Journal of Medicine. 338(23). 1641–1649.639 indexed citations breakdown →
Chaulet, P. (1992). Childhood Tuberculosis, Still with Us.... Medical Entomology and Zoology.2 indexed citations
12.
Chaulet, P, et al.. (1991). L'Approvisionnement en médicaments antituberculeux en 1991 : un problème mondial, un problème national. 6(27). 141–152.1 indexed citations
Chaulet, P. (1989). Integrating tuberculosis control activities into the primary health care system at district level.. PubMed. 64(2). 33–5.1 indexed citations
15.
Chaulet, P. (1989). Tuberculosis: a six-month cure.. PubMed. 10(1). 116–22.5 indexed citations
16.
Chaulet, P. (1986). [Comparison of a 6-month chemotherapy and a l2-month chemotherapy in the treatment of pulmonary tuberculosis in Algerian Sahara. Cooperative study by an Algerian work team and the British Medical Research Council].. PubMed. 60(1-2). 31–3.1 indexed citations
17.
Chaulet, P, et al.. (1982). [An inquiry into the use of antibiotics in acute respiratory infections in primary health care centres in Algeria during 1980 (author's transl)].. PubMed. 10(1). 45–52.1 indexed citations
18.
Chaulet, P, et al.. (1975). LE TRAITEMENT DE RELAIS DE LA TUBERCULOSE PULMONAIRE PAR ADMINISTRATION INTERMITTENTE DE RIFAMPICINE ET D'ETHAMBUTOL. 3(1). 41–48.2 indexed citations
19.
Chaulet, P, et al.. (1970). [Intermittent treatment of "intractable chronic tuberculosis" by combined rifampicin-ethambutol: preliminary results of a controlled survey made in Algeria].. PubMed. 34(4). 559–66.5 indexed citations
20.
Lévi-Valensi, P, et al.. (1963). [The role of tuberculosis in avitaminosis B 6 in tuberculous patients not subjected to antibiotherapy. (Study of 40 patients tested 66 times with the tryptophan loading test)].. PubMed. 39(8). 482–6.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.